Jupiter Neurosciences JUNS
NASDAQ JUNS
$6.20 +1.03 (+19.92%)
At close: Aug 21, 2026 · 4:00 PM EDT

Jupiter Neurosciences (JUNS) Selling, General & Administrative (2023 - 2025)

Jupiter Neurosciences (JUNS) Selling, General & Administrative (2023 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.13 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 216.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 593.21 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 347.92 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -196.26 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 247.47 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 161.89 Mn
10 Jupiter Neurosciences 3.37 Mn 1.85 Mn 21,064.00 2.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.78 Mn
Sep 30, 2025 1.48 Mn
Jun 30, 2025 1.51 Mn
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 401,636.00
Jun 30, 2024 456,000.00
Mar 31, 2024 472,028.00
Dec 31, 2023 290,912.00
Sep 30, 2023 1.20 Mn